UmbriaExplore our travel guides. Share your stories, tips and questions on Reddit.
Fast movers • Alerts • Momentum
10% OFF with SAVE10
Charts • Watchlists • Multi-broker tools
Built for active traders
Biotech catalyst, news and analysis PDUFA tracker
Biotech catalyst, news and analysis PDUFA tracker
THE MERLINTRADER RESEARCH DESK
Independent research on biotech and U.S. small & mid caps. Explore companies, follow FDA and clinical milestones, and put the news in context.
Start with a ticker or company name, or browse the complete Stock Hub index ↗
Clinical data, FDA milestones, pipelines and financing risks.
Explore Stock Hubs ↗Company research across space, defense and emerging technology.
Explore Stock Hubs ↗Energy companies, critical resources and industrial supply chains.
Explore Stock Hubs ↗Company fundamentals, regulation and sector-specific risks.
Explore Stock Hubs ↗Evening update · September 20, 2026: Sunday edition · U.S. equities remain closed. September 18 regular-session ETF closes remain the latest verified reference: SPY $761.69 (-0.12%); QQQ $721.45 (+0.63%); DIA $515.88 (-0.48%); IWM $284.10 (-0.47%). Price changes exclude distributions; SPY and DIA went ex-dividend. Focus: FAYUVI / Ultragenyx, TRex Bio’s S-1, Monday’s reopening and September 24–25 data ahead of August PCE on September 30.
Read the briefing ↗The week in U.S. markets, sector trends and the broader context.
Read the Market Pulse ↗FDA decisions, PDUFA dates and clinical milestones.
Open the calendar ↗Conferences, industry summits and company watchpoints, with an importance scale.
Explore the events ↗Explore the current biotech selection and the research behind it.
Explore the Top Ten ↗Reported insider transactions, company context and filing links.
Read the Insider Weekly ↗Understand clinical trials, biotech catalysts and market risks.
Merlintrader connects company research with the events that shape it. Stock Hubs bring together business context, clinical pipelines, regulatory milestones and financial risks, with links to supporting sources. Biotech is our core focus, alongside research on other U.S. small- and mid-cap sectors.
Use the calendar to explore upcoming events and the Educational Library to understand the terminology and risks. Event dates can change; check the linked company and regulatory sources. Content is educational and informational, not financial advice or a recommendation to trade.
THE CONVERSATION CONTINUES
Have a question, a different take, or feedback on a report? Join r/MerlintraderPub, leave a comment, or send me a message on Reddit. I’d love to hear from you.
Prefer Stocktwits? Follow @Merlintrader and join the discussion there, too.
Join Stocktwits with my referral ↗Referral link: I may receive a benefit if you sign up through this link.
